Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Musella

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Annals of Surgical Oncology|March 25, 2015
Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution ExperienceA Musella, C Marchetti, I Palaia, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|November 1, 2015
PARP inhibition: A promising therapeutic target in ovarian cancerA Musella, C Marchetti, M L Gasparri, et al.
Neuropathology and Applied Neurobiology|May 25, 2019
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neuronsA Gentile, F De Vito, D Fresegna, et al.
British Journal of Pharmacology|August 29, 2012
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisG Grasselli, S Rossi, A Musella, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Annals of Surgical Oncology|March 25, 2015
Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution ExperienceA Musella, C Marchetti, I Palaia, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|November 1, 2015
PARP inhibition: A promising therapeutic target in ovarian cancerA Musella, C Marchetti, M L Gasparri, et al.
Neuropathology and Applied Neurobiology|May 25, 2019
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neuronsA Gentile, F De Vito, D Fresegna, et al.
British Journal of Pharmacology|August 29, 2012
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisG Grasselli, S Rossi, A Musella, et al.
Pageof 3